Description

BSE revises price bands for 33 listed scrips effective February 23, 2026, with bands ranging from 2% to 20% as part of surveillance measures.

Summary

BSE has revised price bands for 33 listed equity scrips effective February 23, 2026. The revised bands range from 2% to 20%, applied as part of BSE’s ongoing surveillance framework to manage price volatility in select securities.

Key Points

  • Price bands revised for 33 scrips effective February 23, 2026
  • Revised bands span 2%, 5%, 10%, and 20% tiers
  • Changes apply to the Equity segment
  • Contact: bse.surv@bseindia.com for clarifications
  • Circular issued under Notice No. 20260220-38

Regulatory Changes

The following price band revisions have been announced:

Scrip CodeScrip NameRevised Price Band (%)
543943Asarfi Hospital Ltd20
512477Betex India Ltd5
512296Bhagyanagar India Ltd10
543926Bizotic Commercial Ltd5
532290BLB Ltd10
540361Danube Industries Ltd10
543272Easy Trip Planners Ltd10
524590Hemo Organic Ltd2
531274Kinetic Trust Ltd5
543464Maruti Interior Products Ltd5
532362Nagpur Power & Industries Ltd5
531834Natura Hue Chem Ltd2
511535NDA Securities Ltd10
519528Norben Tea & Exports Ltd2
513121Oricon Enterprises Ltd20
500143PH Capital Ltd5
512217Prism Medico and Pharmacy Ltd5
539669RGF Capital Markets Ltd2
512047Royal India Corporation Ltd10
538857Scintilla Commercial & Credit Ltd2
531794Seshachal Technologies Ltd5
526883Shikhar Consultants Ltd5
540693Shish Industries Ltd2
530977Shri Keshav Cements And Infra Ltd20
521034Soma Textiles & Industries Ltd2
518053Sri Chakra Cement Ltd10
544001Sunita Tools Ltd5
539985Titaanium Ten Enterprise Ltd5
509953Trade Wings Ltd5
751079Travels & Rentals Limited20
530579U. Y. Fincorp Ltd20
542933Universus Photo Imagings Ltd5
511726Vipul Ltd5

Compliance Requirements

  • Trading members must note revised price bands for the listed scrips and ensure orders placed comply with the new limits from February 23, 2026 onwards
  • Members requiring clarification should contact BSE Surveillance at bse.surv@bseindia.com

Important Dates

  • Circular Date: February 20, 2026
  • Effective Date: February 23, 2026

Impact Assessment

This circular affects traders and investors holding or trading in the 33 specified scrips. Stocks assigned a 2% band (8 scrips) face the tightest restrictions, likely reflecting heightened surveillance concern. Stocks revised to 20% bands (5 scrips: Asarfi Hospital, Oricon Enterprises, Shri Keshav Cements, Travels & Rentals, U.Y. Fincorp) are being given wider trading room, potentially reflecting a relaxation from prior tighter bands. Overall market impact is limited as these are primarily small/mid-cap scrips, but individual stock liquidity and intraday trading strategies will be directly affected.

Impact Justification

Routine surveillance-driven price band revisions affecting 33 scrips. Impacts traders and investors in these specific stocks by restricting daily price movement, but is a standard BSE surveillance action with no systemic market-wide implications.